MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 120 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 1.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,000 | -95.2% | 1,000 | -85.3% | 0.00% | – |
| Q1 2017 | $21,000 | -91.3% | 6,795 | -88.5% | 0.00% | – |
| Q4 2016 | $241,000 | -68.4% | 58,915 | -50.9% | 0.00% | -100.0% |
| Q3 2016 | $762,000 | +1521.3% | 120,091 | +1926.5% | 0.00% | – |
| Q1 2016 | $47,000 | +261.5% | 5,926 | +220.0% | 0.00% | – |
| Q4 2015 | $13,000 | -94.7% | 1,852 | -93.9% | 0.00% | – |
| Q3 2015 | $244,000 | +82.1% | 30,480 | +172.2% | 0.00% | – |
| Q2 2015 | $134,000 | -91.0% | 11,196 | -91.7% | 0.00% | -100.0% |
| Q1 2015 | $1,485,000 | +1568.5% | 135,044 | +1548.5% | 0.00% | – |
| Q4 2014 | $89,000 | -31.0% | 8,192 | -49.1% | 0.00% | – |
| Q3 2014 | $129,000 | -61.6% | 16,099 | -66.5% | 0.00% | – |
| Q2 2014 | $336,000 | +36.6% | 48,076 | -1.9% | 0.00% | – |
| Q1 2014 | $246,000 | -11.5% | 48,988 | -11.7% | 0.00% | – |
| Q4 2013 | $278,000 | +1535.3% | 55,496 | +889.1% | 0.00% | – |
| Q3 2013 | $17,000 | -58.5% | 5,611 | -8.1% | 0.00% | – |
| Q2 2013 | $41,000 | – | 6,105 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,000,000 | $20,400,000 | 4.19% |
| Consonance Capital Management LP | 9,067,998 | $36,997,000 | 4.06% |
| Lagoda Investment Management, L.P. | 1,522,529 | $6,212,000 | 2.13% |
| INDUS CAPITAL PARTNERS, LLC | 1,050,000 | $4,284,000 | 0.56% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 9,072,877 | $37,017,000 | 0.32% |
| GARRISON BRADFORD & ASSOCIATES INC | 77,700 | $317,000 | 0.29% |
| Cannell & Co. | 1,572,978 | $6,418,000 | 0.23% |
| Virtus ETF Advisers LLC | 179,625 | $733,000 | 0.22% |
| LeJeune Puetz Investment Counsel LLC | 3,976 | $161,000 | 0.12% |
| STONERIDGE INVESTMENT PARTNERS LLC | 221,838 | $905,000 | 0.12% |